^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

TG 100-115

i
Other names: TG100-115, TG 100-115, TG100115
Associations
Trials
Company:
Sanofi
Drug class:
PI3K inhibitor
Related drugs:
Associations
Trials
almost2years
[6]-Gingerol induces Caspase-Dependent Apoptosis in Bladder Cancer cells via MAPK and ROS Signaling. (PubMed, Int J Med Sci)
Further, [6]-GIN also increased the intracellular reactive oxygen species (ROS) levels and TG100-115 or tranilast increased [6]-GIN‑induced cell death. These results suggest that [6]-GIN induced apoptosis in the bladder cancer cell line 5637 and therefore has the potential to be used in the development of new drugs for bladder cancer treatment.
Journal
|
BIRC5 (Baculoviral IAP repeat containing 5) • BAX (BCL2-associated X protein) • CASP3 (Caspase 3) • CASP9 (Caspase 9)
|
TG 100-115
almost4years
Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells. (PubMed, J Cell Physiol)
Furthermore, we showed that the synergistic interaction might be associated with TRPM7 channel activities using combination treatments of TRAIL and TRPM7 inhibitors (NS8593 as a TRPM7 channel inhibitor and TG100-115 as a TRPM7 kinase inhibitor). We reveal that downregulation of cellular FLICE-inhibitory protein via inhibition of Ca influx might be involved in the synergistic interaction. Our study would provide both a new role of TRPM7 in TNBC cell apoptosis and a potential combinatorial therapeutic strategy using TRPM7 inhibitors with TRAIL in the treatment of TNBC.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha)
|
TG 100-115